Annual ROE
-71.29%
-20.39%-40.06%
December 31, 2023
Summary
- As of February 7, 2025, TCRX annual return on equity is -71.29%, with the most recent change of -20.39% (-40.06%) on December 31, 2023.
- During the last 3 years, TCRX annual ROE has fallen by -132.82% (-215.86%).
- TCRX annual ROE is now -189.46% below its all-time high of 79.69%, reached on December 31, 2019.
Performance
TCRX ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-60.03%
-1.28%-2.18%
September 30, 2024
Summary
- As of February 7, 2025, TCRX quarterly return on equity is -60.03%, with the most recent change of -1.28% (-2.18%) on September 30, 2024.
- Over the past year, TCRX quarterly ROE has increased by +7.53% (+11.15%).
- TCRX quarterly ROE is now -190.87% below its all-time high of 66.06%, reached on June 30, 2021.
Performance
TCRX Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
TCRX ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -40.1% | +11.2% |
| 3 y3 years | -215.9% | +11.2% |
| 5 y5 years | -189.5% | +11.2% |
TCRX ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -40.1% | +13.3% | -41.8% | +55.0% |
| 5 y | 5-year | -189.5% | +13.3% | -190.9% | +92.3% |
| alltime | all time | -189.5% | +13.3% | -190.9% | +92.3% |
TScan Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -60.03%(+2.2%) |
| Jun 2024 | - | -58.75%(-13.6%) |
| Mar 2024 | - | -68.03%(+4.9%) |
| Dec 2023 | -71.29%(+40.1%) | -64.85%(-4.0%) |
| Sep 2023 | - | -67.56%(+2.1%) |
| Jun 2023 | - | -66.17%(+4.1%) |
| Mar 2023 | - | -63.55%(+25.6%) |
| Dec 2022 | -50.90% | -50.61%(+19.6%) |
| Sep 2022 | - | -42.33%(-23.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | -55.50%(-27.7%) |
| Mar 2022 | - | -76.73%(-42.4%) |
| Dec 2021 | -82.20%(-233.6%) | -133.26%(-82.9%) |
| Sep 2021 | - | -779.91%(-1280.6%) |
| Jun 2021 | - | 66.06%(+7.1%) |
| Mar 2021 | - | 61.70%(+0.3%) |
| Dec 2020 | 61.53%(-22.8%) | - |
| Dec 2020 | - | 61.53% |
| Dec 2019 | 79.69% | - |
FAQ
- What is TScan Therapeutics annual return on equity?
- What is the all time high annual ROE for TScan Therapeutics?
- What is TScan Therapeutics annual ROE year-on-year change?
- What is TScan Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for TScan Therapeutics?
- What is TScan Therapeutics quarterly ROE year-on-year change?
What is TScan Therapeutics annual return on equity?
The current annual ROE of TCRX is -71.29%
What is the all time high annual ROE for TScan Therapeutics?
TScan Therapeutics all-time high annual return on equity is 79.69%
What is TScan Therapeutics annual ROE year-on-year change?
Over the past year, TCRX annual return on equity has changed by -20.39% (-40.06%)
What is TScan Therapeutics quarterly return on equity?
The current quarterly ROE of TCRX is -60.03%
What is the all time high quarterly ROE for TScan Therapeutics?
TScan Therapeutics all-time high quarterly return on equity is 66.06%
What is TScan Therapeutics quarterly ROE year-on-year change?
Over the past year, TCRX quarterly return on equity has changed by +7.53% (+11.15%)